Computer-assisted image analysis of neovascularization in thtyroid neoplasms from dogs

American Journal of Veterinary Research

Volumn 63, Issue 3, 2002, Pages 363-369

  Kent, Michael S ^a   Griffey, Stephen M ^a   Verstraete, Frank J M ^a   Naydan, Diane ^a   Madewell, Bruce R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; DOXORUBICIN; IMMUNOGLOBULIN G; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CALCULATION; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DOG DISEASE; DRUG RESPONSE; FEMALE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; QUANTITATIVE ANALYSIS; SURVIVAL TIME; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOMA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036521280     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.363     Document Type: Article

References (41)

1. Ramsden JD. Angiogenesis in the thyroid gland. J Endocrinol 2000;166:475-480.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
3. Belien JAM, van Diest PJ, Baak JPA. Relationships between vascularization and proliferation in invasive breast cancer. J Pathol 1999;189:309-318.
4. Harris AL. Antiangiogenesis for cancer therapy. Lancet 1997;349(suppl 2):13-15.
5. Weidner N. Tumour vascularity and proliferation: clear evidence of a close relationship. J Pathol 1999;189:297-299.
6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
7. Vermeulen PB, Libura M, Libura J, et al. influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat 1997;42: 165-172.
8. Simpson JF, Ahn C, Battifora H, et al. Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 1996;77: 2077-2085.
9. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-782.
10. de Jong JS, van Diest PJ, Baak JPA. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36:306-312.
11. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
12. Schoell WM, Pieber D, Reich O, et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer 1997;80:2257-2262.
13. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, et al. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 1999; 86:1421-1430.
14. Lingen MW. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. Crit Rev Oral Biol Med 1999;10:153-164.
15. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
16. Rogatsch H, Hittmair A, Reissigl A, et al. Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor? J Pathol 1997;182:205-210.
17. Griffey SM, Verstraete FJ, Kraegel SA, et al. Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs. Am J Vet Res 1998;59:1238-1242.
18. Graham JC, Myers RK. The prognostic significance of angiogenesis in canine mammary tumors. J Vet Intern Med 1999;13:416-418.
19. Restucci B, De Vico G, Maiolino P. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry. Vet Pathol 2000;37: 297-301.
20. Coomber BL, Denton J, Sylvestre A, et al. Blood vessel density in canine osteosarcoma. Can J Vet Res 1998;62:199-204.
21. Gonzalez CM, Griffey SM, Naydan DK, et al. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumors in growth phase and during regression after chemotherapy. J Comp Pathol 2000;122:241-248.
22. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
23. Olivry T, Naydan D, Moore P. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 1997;19:477-486.
24. Staibano S, Boscaino A, Salvatore G, et al. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol 1996;27:695-700.
25. Dellas A, Moch H, Schultheiss E, et al. Angiogenesis in cervical neoplasia: microvessel quantitation in precancercus lesions and invasive carcinomas with clinicopathological correlations. Gynecol Oncol 1997;67:27-33.
26. Zhu PD, Gu Z. Observation of the activity of factor VIII in the endometrium of women with regular menstrual cycles. Hum Reprod 1988;3:273-275.
27. Yang S, Graham J, Kahn J, et al. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 1999;155:887-895.
28. Kuzu I, Bicknell R, Harris AL, et al. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 1992;45:143-148.
29. Akslen LA, Livolsi VA. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol 2000;31:439-442.
30. Fontanini G, Vignati S, Pacini F, et al. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. Mod Pathol 1996;9:636-641.
31. Tsuchiya A, Suzuki S, Kanno M, et al. Prognostic factors associated with differentiated thyroid cancer. Surg Today 1995;25:778-782.
32. Moreno-Egea A, Rodriguez-Gonzalez JM, Sola-Perez J, et al. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 1995; 82:1092-1094.
33. Schlumberger MJ, Torlantano M. Papillary and follicular thyroid carcinoma. Baillieres Best Pract Res Clin Endocrinol Metab 2000;14:601-613.
34. Fineman LS, Hamilton TA, de Gortari A, et al. Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. J Am Anim Hosp Assoc 1998;34:109-112.
35. Carver JR, Kapatkin A, Patnaik AK. A comparison of medullary thyroid carcinoma and thyroid adenocarcinoma in dogs: a retrospective study of 38 cases. Vet Surg 1995;24:315-319.
36. Harari J. Patterson JS, Rosenthal RC. Clinical and pathologic features of thyroid tumors in 26 dogs. J Am Vet Med Assoc 1986; 188:1160-1164.
37. Jeglum KA, Whereat A. Chemotherapy of canine thyroid carcinoma. Compend Contin Educ Pract Vet 1983;5:96-98.
38. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34:148-155.
39. Jensen JH, Chandra R. MR imaging of microvasculature. Magn Reson Med 2000;44:224-230.
40. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999;10:903-907.
41. Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker (99m) technetium-labeled 2,2′-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Res 2000;60:4582-4588.